Design, synthesis and evaluation of halogenated furanone derivatives as quorum sensing inhibitors in Pseudomonas aeruginosa. 2019

Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug Development of Chinese Ministry of Education, College of Pharmacy, Jinan University, Guangzhou 510632; PR China; Faculty of Medicine and Health, the University of Sydney, Sydney, NSW 2006, Australia.

The biofilm formation of Pseudomonas aeruginosa (P. aeruginosa) is regulated by a phenomenon of quorum sensing (QS). With 5-hydroxyl-3,4-halogenated-5H-furan-2-ones as beginning, analogs bearing alkyl chains, vinyl bromide, or aromatic rings were designed and synthesized. The minimum inhibitory concentration (MIC) of the compounds against P. aeruginosa was assayed and the biofilm inhibition ratio was determined at different concentrations lower than the MIC. C-5 aromatic substituted furanones showed remarkable biofilm formation as well as inhibition of virulence factor production in P. aeruginosa. Fluorescence report analysis identified the QS regulatory mechanism of the most active compound 29. This study provides us a novel candidate for combating drug resistant bacteria strains by merely inhibiting biofilm formation. Without suppressing the regular life cycle of the bacteria, bacterial resistance mechanisms may not be activated.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D053038 Quorum Sensing A phenomenon where microorganisms communicate and coordinate their behavior by the accumulation of signaling molecules. A reaction occurs when a substance accumulates to a sufficient concentration. This is most commonly seen in bacteria. Quorum Quenching,Quenching, Quorum,Quenchings, Quorum,Quorum Quenchings,Sensing, Quorum
D054879 Halogenation Covalent attachment of HALOGENS to other compounds. Bromination,Chlorination,Fluorination,Iodination,Iodation
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
August 2008, Applied microbiology and biotechnology,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
December 2023, Journal of enzyme inhibition and medicinal chemistry,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
February 2020, Journal of medical microbiology,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
January 2002, Microbiology (Reading, England),
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
May 2020, European journal of medicinal chemistry,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
May 2024, Molecules (Basel, Switzerland),
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
December 2022, Heliyon,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
August 2007, Journal of chemotherapy (Florence, Italy),
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
May 2024, European journal of medicinal chemistry,
Yiqun Chang, and Peng-Cheng Wang, and Hong-Ming Ma, and Si-Yu Chen, and Yu-Hang Fu, and Yuan-Yuan Liu, and Xuan Wang, and Guang-Chao Yu, and Tao Huang, and David E Hibbs, and Hai-Bo Zhou, and Wei-Min Chen, and Jing Lin, and Chao Wang, and Jun-Xia Zheng, and Ping-Hua Sun
May 2018, Molecules (Basel, Switzerland),
Copied contents to your clipboard!